Stress Levels Periodontitis and Metabolic Syndrome
Evaluation of Salivary Cortisol, Dehydroepiandrosterone, Chromogranin A, and Psychological Stress Levels in Patients With Periodontitis and Metabolic Syndrome
The purpose of this observational study is to evaluate the levels of salivary cortisol, dehydroepiandrosterone, and chromogranin A, as well as the levels of psychological stress, in patients with periodontitis and/or metabolic syndrome. The primary research question the study aims to address is:
- Are the levels of salivary cortisol, dehydroepiandrosterone, and chromogranin A and psychological stress in patients with periodontitis and/or metabolic syndrome associated with their periodontal status and metabolic syndrome?
Participants-categorized into a control group, those with periodontitis only, those with metabolic syndrome only, and those with both periodontitis and metabolic syndrome-will undergo a clinical periodontal examination, provide saliva samples for the assessment of cortisol, dehydroepiandrosterone, and chromogranin A levels, and complete validated scales designed to measure psychological stress. The findings will help clarify the relationship between psychological stress, stress-related salivary biomarkers, metabolic syndrome, and periodontal health.
Studienübersicht
Status
Status
Bedingungen
Bedingungen
Detaillierte Beschreibung
Within the scope of the study, the Rosenberg Self-Esteem Scale and the Social Appearance Anxiety Scale will be administered. Salivary markers-cortisol, dehydroepiandrosterone, and chromogranin A-will be analyzed using the ELISA method. Periodontal clinical parameters (plaque index, gingival index, bleeding on probing, probing pocket depth, and clinical attachment loss) will be measured.
Studientyp
Studientyp
Einschreibung (Geschätzt)
Einschreibung
Kontakte und Standorte
Studienkontakt
Studienkontakt
- Name: Oguz KOSE, Professor Dr.
- Telefonnummer: +90 541 348 64 65
- E-Mail: oguz.kose@erdogan.edu.tr
Studienorte
-
-
Rize Province
-
Rize, Rize Province, Türkei (türkiye), 53020
- Department of Periodontology of the Faculty of Dentistry of Recep Tayyip Erdogan University
-
Kontakt:
- RTEU Faculty of Dentistry, Department of Periodontology
- Telefonnummer: +90 464 222 00 00
- E-Mail: dis@erdogan.edu.tr
-
-
Teilnahmekriterien
Zulassungskriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
Individuals who presented to the Internal Medicine Outpatient Clinic at the Recep Tayyip Erdoğan University Faculty of Medicine Training and Research Hospital and met the diagnostic criteria for metabolic syndrome as defined by the American Diabetes Association (ADA) or the International Diabetes Federation (IDF); healthy volunteers who presented to the Periodontology Clinic at the Recep Tayyip Erdoğan University Faculty of Dentistry; and individuals who were diagnosed with periodontitis but did not meet the criteria for metabolic syndrome.
Beschreibung
Inclusion Criteria:
- Individuals between the ages of 18 and 65,
- Those who have at least 20 natural teeth,
- Individuals who have provided written informed consent for participation in the research
- Individuals diagnosed with periodontitis and/or metabolic syndrome
Exclusion Criteria:
- Individuals who have received periodontal treatment (surgical or non-surgical) within the last 6 months,
- Individuals with a history of using antibiotics, anti-inflammatory drugs, or immunosuppressive medications within the last 3 months,
- Individuals with a history of systemic disease who do not meet the criteria for metabolic syndrome (e.g., malignancy, autoimmune diseases, liver/kidney failure),
- Individuals who have been diagnosed with a psychiatric disorder or are undergoing regular psychiatric treatment,
- Pregnant or breastfeeding women,
- Individuals with physical or mental disabilities that prevent them from maintaining their oral hygiene.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Beobachtungsmodelle: CASE_CONTROL
- Zeitperspektiven: PROSPECTIVE
Anzahl der Gruppen / Kohorten
Kohorten und Interventionen
Gruppe / KohorteGruppe / Kohorte |
|---|
|
Healthy Control Group
Individuals with no clinical or radiographic signs of periodontal disease and no history of systemic disease |
|
Periodontitis Group (Systemically Healthy)
Individuals diagnosed with periodontitis according to the 2018 American Academy of Periodontology classification, but with no history of systemic disease |
|
Metabolic Syndrome Group (Periodontally Healthy)
Individuals diagnosed with metabolic syndrome according to American Diabetes Association or International Diabetes Federation criteria, but without periodontitis |
|
Periodontitis + Metabolic Syndrome Group
Individuals diagnosed with both metabolic syndrome and periodontitis |
Was misst die Studie?
Primäre Ergebnismessungen
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Plaque Index
Zeitfenster: Day 1
|
Plaque Index (PI) (Silness and Löe, 1964) This index is used to evaluate the amount of dental plaque accumulation on tooth surfaces. Each tooth's four surfaces (buccal, lingual, mesial, distal) are examined using a probe or visually. Each surface is scored from 0 to 3. The average score is calculated for each tooth. The overall plaque index is obtained by averaging the scores from all examined teeth. Score Description 0 No plaque.
|
Day 1
|
|
Gingival Index
Zeitfenster: Day 1
|
The Gingival Index is used to assess the presence and severity of gingival inflammation (gingivitis). Four surfaces of each tooth (buccal, lingual, mesial, distal) are examined visually and with a periodontal probe. The evaluation considers color changes, edema (swelling), tissue consistency, and bleeding on probing. Each surface is scored from 0 to 3. The average score per tooth is calculated, and then the overall average is used to determine the individual's GI score. Score Description 0 Healthy gingiva: normal color and texture, no bleeding
|
Day 1
|
|
Bleeding on Probing Index
Zeitfenster: Day 1
|
This index is used to assess the presence and severity of gingival inflammation by observing bleeding after gentle pressure is applied to the gingival sulcus using a periodontal probe. A thin periodontal probe is gently inserted into the gingival sulcus with light pressure (approximately 20-25 grams). Bleeding occurring within 10-30 seconds is observed. Each measurement site is recorded as either "bleeding present" or "bleeding absent." Presence of bleeding is an early and sensitive indicator of gingival inflammation. Score Description: 0 No bleeding 1 Bleeding present (mild or severe) |
Day 1
|
|
Probing Pocket Depth
Zeitfenster: Day 1
|
Using a Williams periodontal probe, the distance between the gingival margin and the base of the periodontal pocket is measured in millimeters at six sites per tooth: mesiobuccal, midbuccal, distobuccal, mesiolingual, midlingual, and distolingual. All teeth are measured. The values obtained from each site are summed and then divided by the total number of sites measured. This gives the average probing depth for the individual. Measurement Interpretation 1-3 mm Healthy sulcus 4-5 mm Shallow to moderate pocket ≥6 mm Deep periodontal pocket (advanced disease) |
Day 1
|
|
Clinical Attachment Loss
Zeitfenster: Day 1
|
Using a Williams periodontal probe, the distance between the enamel-cementum junction and the base of the periodontal pocket is measured in millimeters at six sites per tooth: mesiobuccal, midbuccal, distobuccal, mesiolingual, midlingual, and distolingual. All teeth are measured. The values obtained from each site are summed and then divided by the total number of sites measured. This gives the average probing depth for the individual. Clinical Attachment Loss Value Interpretation 0-1 mm Healthy / minimal loss 2-3 mm Mild attachment loss 4-5 mm Moderate attachment loss ≥6 mm Severe attachment loss |
Day 1
|
|
Collection of Saliva Samples
Zeitfenster: Day 2
|
Prior to saliva collection, participants will be instructed to abstain from caffeine and/or nicotine for at least 4 hours and alcohol for at least 24 hours. Saliva will be collected between 9:00 AM and 11:00 AM to minimize circadian variations. Unstimulated saliva flow rate will be collected over 10 minutes using the spitting method and will be expressed in mL/min. |
Day 2
|
Sekundäre Ergebnismessungen
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Rosenberg Self-Esteem Scale Score
Zeitfenster: Day 1
|
A four-point scale will be used to score responses to the 10 items. Positive questions are scored as 3: Strongly agree; 2: Agree; 1: Disagree; and 0: Strongly disagree, while negative questions are scored as 0: Strongly agree; 1: Agree; 2: Disagree; and 3: Strongly disagree. According to the final total score of the Rosenberg Self-Esteem Scale scores between 0-15, 15-25, and 25-30 indicate low, normal, and high self-esteem levels, respectively. |
Day 1
|
|
Social Appearance Anxiety Scale Score
Zeitfenster: Day 1
|
Social Appearance Anxiety Scale 16-item scale concerns how patients feel about their appearance. A score of 1 to 5 is given for each item as follows: 1, completely disagree; 2, partially disagree; 3, unsure; 4, partially agree; 5, I completely agree. Scores range from 16 to 80, with higher scores representing greater social appearance anxiety. |
Day 1
|
|
Concentration of Cortisol, Dehydroepiandrosterone and Chromogranin A
Zeitfenster: approximately in the 4th month
|
Salivary cortisol, Dehydroepiandrosterone and Chromogranin A will be obtained from unstimulated whole saliva samples. Saliva samples will be stored at -20°C until analyzed. Human salivary cortisol, Dehydroepiandrosterone, and Chromogranin A will be measured using radioenzyme immunoassay using a commercial enzyme-linked immunosorbent assay (ELISA) kit according to the manufacturer's instructions. |
approximately in the 4th month
|
Mitarbeiter und Ermittler
Sponsor
Sponsor
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Studienbeginn
Primärer Abschluss (Geschätzt)
Primärer Abschluss
Studienabschluss (Geschätzt)
Studienabschluss
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Zuerst gepostet
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes Update gepostet
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
Andere Studien-ID-Nummern
- Salivary Stress-MetS-Perio
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .